Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 4, 2011, Pages 745-750

  Lin, Ming Tzung ^a   Chen, Chao Long ^a   Wang, Chih Chi ^a   Cheng, Yu Fan ^a   Eng, Hock Liew ^a   Wang, Jing Houng ^a   Chiu, King Wah ^a   Lee, Chuan Mo ^a   Hu, Tsung Hui ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Hepatocellular carcinoma; Imaging; Liver cirrhosis; Sensitivity

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; TUMOR VOLUME; ULTRASOUND;

EID: 79952827454     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06501.x     Document Type: Article

References (37)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
2. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981; 2: 1129-33.
3. Tsukuma H, Hiyama T, Tanaka S etal. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 1993; 328: 1797-801.
4. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127: 1372-80.
5. Huang GT, Sheu JC, Yang PM, Lee HS, Wang TH, Chen DS. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma-a study based on 420 patients. J. Hepatol. 1996; 25: 334-8.
6. Takamori R, Wong LL, Dang C, Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl. 2000; 6: 67-72.
7. Durand F, Regimbeau JM, Belghiti J etal. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J. Hepatol. 2001; 35: 254-8.
8. Colli A, Fraquelli M, Casazza G etal. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am. J. Gastroenterol. 2006; 101: 513-23.
9. van Leeuwen MS, Noordzij J, Feldberg MA, Hennipman AH, Doornewaard H. Focal liver lesions: characterization with triphasic spiral CT. Radiology 1996; 201: 327-36.
10. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
11. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J. Clin. Ultrasound 1993; 21: 303-8.
12. Knodell RG, Ishak KG, Black WC etal. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
13. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-16.
14. Lai HW, Hsiung HY, Tai JJ, Chen SI, Chang HC, Chen TH. Ethnic-specific prevalence of hepatitis B/C virus infection in Pin-Jen, Taiwan. Ethn. Dis. 2009; 19: 384-9.
15. Tiribelli C, Melato M, Crocè LS, Giarelli L, Okuda K, Ohnishi K. Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world-Trieste, Italy, and Chiba, Japan. Hepatology 1989; 10: 998-1002.
16. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am. J. Clin. Pathol. 1996; 105: 65-75.
17. Smalley SR, Moertel CG, Hilton JF etal. Hepatoma in the noncirrhotic liver. Cancer 1988; 62: 1414-24.
18. Winston CB, Schwartz LH, Fong Y, Blumgart LH, Panicek DM. Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 1999; 210: 75-9.
19. Bruix J, Sherman M, Llovet JM etal. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J. Hepatol. 2001; 35: 421-30.
20. Saar B, Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma. Liver Int. 2008; 28: 189-99.
21. Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J. Gastroenterol. 2009; 15: 1301-14.
22. Baron RL, Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 2004; 127: S133-143.
23. Kim T, Murakami T, Takahashi S etal. Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images. Abdom. Imaging 1999; 24: 473-80.
24. França AV, Elias Junior J, Lima BL, Martinelli AL, Carrilho FJ. Diagnosis, staging and treatment of hepatocellular carcinoma. Braz. J. Med. Biol. Res. 2004; 37: 1689-705.
25. Ikeda K, Saitoh S, Koida I etal. Imaging diagnosis of small hepatocellular carcinoma. Hepatology 1994; 20: 82-7.
26. Ishiguchi T, Shimamoto K, Fukatsu H, Yamakawa K, Ishigaki T. Radiologic diagnosis of hepatocellular carcinoma. Semin. Surg. Oncol. 1996; 12: 164-9.
27. Yu SC, Yeung DT, So NM. Imaging features of hepatocellular carcinoma. Clin. Radiol. 2004; 59: 145-56.
28. Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn. Reson. Imaging Clin. N. Am. 2002; 10: 31-52.
29. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am. J. Roentgenol. 2003; 180: 441-54.
30. Snowberger N, Chinnakotla S, Lepe RM etal. Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment. Pharmacol. Ther. 2007; 26: 1187-94.
31. Ohashi I, Hanafusa K, Yoshida T. Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation. Radiology 1993; 189: 851-5.
32. Fernández M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogenesis in liver disease. J. Hepatol. 2009; 50: 604-20.
33. Libbrecht L, Bielen D, Verslype C etal. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl. 2002; 8: 749-61.
34. Ikeda K, Saitoh S, Koida I etal. Diagnosis and follow-up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography. Hepatology 1993; 17: 1003-7.
35. Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004; 127: S108-112.
36. Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J. Gastroenterol. Hepatol. 2001; 16: 553-9.
37. Trevisani F, D'Intino PE, Morselli-Labate AM etal. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J. Hepatol. 2001; 34: 570-5.